Zioglim MV 1
Glimepiride, Voglibose & Metformin Hydrochloride (SR) Tablets – The combination of Glimepiride, Metformin, and Voglibose is utilized in adults for the management of type 2 diabetes mellitus when dietary measures, exercise, and individual therapies with two medications are inadequate to sufficiently regulate blood sugar levels. It serves as a combination of medications aimed at treating type 2 diabetes mellitus in adults. It aids in controlling blood sugar levels in individuals diagnosed with diabetes.
Glimepiride—1 mg Metformin Hydrochloride (SR) 500 mg Voglibose–0.2 mg
Glimepiride, Voglibose & Metformin Hydrochloride (SR) Tablets
This is a medication that assists in controlling elevated blood glucose levels. It aids in slowing the conversion of food in our intestines to simple sugar, thereby reducing the surge in blood glucose levels following meals. It also facilitates the elimination of excess glucose from your body through urine. Reducing blood glucose levels is a crucial aspect of diabetes management.
Glimepiride, Voglibose & Metformin Hydrochloride (SR) Tablets will decrease the likelihood of mortality from cardiovascular disease for those with type 2 diabetes who already have cardiovascular disease. Regular use of this medication, alongside a balanced diet and exercise, will assist you in leading a normal, healthy lifestyle.
The mechanism through which glimepiride lowers blood glucose seems to rely on stimulating the release of insulin from functioning pancreatic beta cells and enhancing the sensitivity of peripheral tissues to insulin. Metformin enhances glucose tolerance in patients with type-2 diabetes (NIDDM), resulting in a reduction of both basal and postprandial plasma glucose. Metformin diminishes hepatic glucose production, decreases the intestinal absorption of glucose, and enhances insulin sensitivity by promoting peripheral glucose uptake and usage.
The combination is recommended for the treatment of type 2 diabetes when diet and exercise alone fail to deliver sufficient glycemic control.
The dosage may differ, and it should be established by a healthcare professional based on the patient’s specific requirements and treatment response.
composition | Each uncoated bilayered tablet contains:- Glimepiride—1 mg Metformin Hydrochloride SR———–500 mg Voglibose–0.2 mg |
---|---|
Packing | 10*15 Blister |
Reviews
There are no reviews yet.